{"id":783,"date":"2024-12-20T22:08:00","date_gmt":"2024-12-20T22:08:00","guid":{"rendered":"https:\/\/vigilantbiosciences.com\/?p=783"},"modified":"2025-05-03T00:46:55","modified_gmt":"2025-05-03T00:46:55","slug":"breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection","status":"publish","type":"post","link":"https:\/\/vigilantbiosciences.com\/de\/aufschlusselung-der-biomarker-wie-das-bevigilant-orafusion-system-die-fruherkennung-von-mundkrebs-neu-definiert\/","title":{"rendered":"Biomarker im Detail: Wie das BeVigilant\u2122 OraFusion\u2122-System die Fr\u00fcherkennung von Mundkrebs neu definiert"},"content":{"rendered":"<p>[et_pb_section fb_built=\u201d1\u2033 _builder_version=\u201d4.16\u2033 locked=\u201doff\u201d global_colors_info=\u201d{}\u201d][et_pb_row _builder_version=\u201d4.16\u2033 background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201drepeat\u201d global_colors_info=\u201d{}\u201d][et_pb_column type=\u201d4_4\u2033 _builder_version=\u201d4.16\u2033 custom_padding=\u201d|||\u201d global_colors_info=\u201d{}\u201d custom_padding__hover=\u201d|||\u201d][et_pb_text _builder_version=\u201d4.22.2\u2033 header_2_font_size=\u201d24px\u201d header_2_line_height=\u201d1.4em\u201d background_size=\u201dinitial\u201d background_position=\u201dtop_left\u201d background_repeat=\u201drepeat\u201d custom_margin=\u201d30px||||false|false\u201d custom_padding=\u201d||0px||false|false\u201d global_colors_info=\u201d{}\u201d]<\/p>\n<p><em data-start=\"152\" data-end=\"174\">Aktuelle Krebsnachrichten<\/em> Der Artikel beleuchtet, wie Vigilant Biosciences\u00ae mit seinem BeVigilant\u2122 OraFusion\u2122 System die Fr\u00fcherkennung von Mundkrebs vorantreibt. Der Kieferchirurg Dr. William Shepard erl\u00e4utert, wie dieser biomarkerbasierte Speicheltest die Risikobewertung und die Entscheidungsfindung von \u00c4rzten bei der Intensivierung der Behandlung ver\u00e4ndert. Durch die Kombination klinischer Daten mit der KI-gest\u00fctzten Analyse von Proteinmarkern bietet das System eine pr\u00e4zisere, nicht-invasive Methode zur Fr\u00fcherkennung von Krebserkrankungen und erm\u00f6glicht Zahn\u00e4rzten ein sichereres und proaktiveres Vorgehen. <br \/><a href=\"https:\/\/breakingcancernews.com\/2024\/12\/10\/detecting-oral-cancer-early-with-biomarkers\/\">Den vollst\u00e4ndigen Artikel finden Sie hier.<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>Breaking Cancer News beleuchtet, wie Vigilant Biosciences\u00ae mit seinem BeVigilant\u2122 OraFusion\u2122 System die Fr\u00fcherkennung von Mundkrebs vorantreibt. Der Artikel enth\u00e4lt Einblicke des Kieferchirurgen Dr. William Shepard, der erl\u00e4utert, wie dieser biomarkerbasierte Speicheltest die Risikobewertung und die Entscheidung \u00fcber eine Intensivierung der Behandlung durch \u00c4rzte ver\u00e4ndert. Durch die Kombination klinischer Daten mit [\u2026]<\/p>","protected":false},"author":9,"featured_media":779,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-783","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Breaking Down Biomarkers: How the BeVigilant\u2122 OraFusion\u2122 System is Redefining Early Oral Cancer Detection - Vigilant Biosciences\u00ae<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vigilantbiosciences.com\/de\/aufschlusselung-der-biomarker-wie-das-bevigilant-orafusion-system-die-fruherkennung-von-mundkrebs-neu-definiert\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breaking Down Biomarkers: How the BeVigilant\u2122 OraFusion\u2122 System is Redefining Early Oral Cancer Detection - Vigilant Biosciences\u00ae\" \/>\n<meta property=\"og:description\" content=\"Patient Resources Understanding the Risk of Oral CancerThe Impact of Oral Cancer In the US alone, oral cancer kills an average one person per hour, 24 hours per day.1Oral cancer is a global challenge with more than 657,000 cases and nearly 330,000 deaths each year1Worldwide 5-year survival rate is only 50% due to delayed intervention [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vigilantbiosciences.com\/de\/aufschlusselung-der-biomarker-wie-das-bevigilant-orafusion-system-die-fruherkennung-von-mundkrebs-neu-definiert\/\" \/>\n<meta property=\"og:site_name\" content=\"Vigilant Biosciences\u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/VigilantBiosciences1\" \/>\n<meta property=\"article:published_time\" content=\"2024-12-20T22:08:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-05-03T00:46:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/VIG_40.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1500\" \/>\n\t<meta property=\"og:image:height\" content=\"1125\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Rachel LaBreck\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Rachel LaBreck\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 Minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/\"},\"author\":{\"name\":\"Rachel LaBreck\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753\"},\"headline\":\"Breaking Down Biomarkers: How the BeVigilant\u2122 OraFusion\u2122 System is Redefining Early Oral Cancer Detection\",\"datePublished\":\"2024-12-20T22:08:00+00:00\",\"dateModified\":\"2025-05-03T00:46:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/\"},\"wordCount\":193,\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"de-DE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/\",\"name\":\"Breaking Down Biomarkers: How the BeVigilant\u2122 OraFusion\u2122 System is Redefining Early Oral Cancer Detection - Vigilant Biosciences\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\"},\"datePublished\":\"2024-12-20T22:08:00+00:00\",\"dateModified\":\"2025-05-03T00:46:55+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vigilantbiosciences.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Breaking Down Biomarkers: How the BeVigilant\u2122 OraFusion\u2122 System is Redefining Early Oral Cancer Detection\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"name\":\"Vigilant Biosciences\u00ae\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vigilantbiosciences.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\",\"name\":\"Vigilant Biosciences\u00ae\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"contentUrl\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Vigilant Biosciences\u00ae\"},\"image\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/VigilantBiosciences1\",\"https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753\",\"name\":\"Rachel LaBreck\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g\",\"caption\":\"Rachel LaBreck\"},\"url\":\"https:\/\/vigilantbiosciences.com\/de\/author\/rachel-labreck\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Breaking Down Biomarkers: How the BeVigilant\u2122 OraFusion\u2122 System is Redefining Early Oral Cancer Detection - Vigilant Biosciences\u00ae","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vigilantbiosciences.com\/de\/aufschlusselung-der-biomarker-wie-das-bevigilant-orafusion-system-die-fruherkennung-von-mundkrebs-neu-definiert\/","og_locale":"de_DE","og_type":"article","og_title":"Breaking Down Biomarkers: How the BeVigilant\u2122 OraFusion\u2122 System is Redefining Early Oral Cancer Detection - Vigilant Biosciences\u00ae","og_description":"Patient Resources Understanding the Risk of Oral CancerThe Impact of Oral Cancer In the US alone, oral cancer kills an average one person per hour, 24 hours per day.1Oral cancer is a global challenge with more than 657,000 cases and nearly 330,000 deaths each year1Worldwide 5-year survival rate is only 50% due to delayed intervention [&hellip;]","og_url":"https:\/\/vigilantbiosciences.com\/de\/aufschlusselung-der-biomarker-wie-das-bevigilant-orafusion-system-die-fruherkennung-von-mundkrebs-neu-definiert\/","og_site_name":"Vigilant Biosciences\u00ae","article_publisher":"https:\/\/www.facebook.com\/VigilantBiosciences1","article_published_time":"2024-12-20T22:08:00+00:00","article_modified_time":"2025-05-03T00:46:55+00:00","og_image":[{"width":1500,"height":1125,"url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/VIG_40.jpg","type":"image\/jpeg"}],"author":"Rachel LaBreck","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"Rachel LaBreck","Gesch\u00e4tzte Lesezeit":"1 Minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/#article","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/"},"author":{"name":"Rachel LaBreck","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753"},"headline":"Breaking Down Biomarkers: How the BeVigilant\u2122 OraFusion\u2122 System is Redefining Early Oral Cancer Detection","datePublished":"2024-12-20T22:08:00+00:00","dateModified":"2025-05-03T00:46:55+00:00","mainEntityOfPage":{"@id":"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/"},"wordCount":193,"publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"articleSection":["News"],"inLanguage":"de-DE"},{"@type":"WebPage","@id":"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/","url":"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/","name":"Breaking Down Biomarkers: How the BeVigilant\u2122 OraFusion\u2122 System is Redefining Early Oral Cancer Detection - Vigilant Biosciences\u00ae","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/#website"},"datePublished":"2024-12-20T22:08:00+00:00","dateModified":"2025-05-03T00:46:55+00:00","breadcrumb":{"@id":"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vigilantbiosciences.com\/breaking-down-biomarkers-how-the-bevigilant-orafusion-system-is-redefining-early-oral-cancer-detection\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vigilantbiosciences.com\/"},{"@type":"ListItem","position":2,"name":"Breaking Down Biomarkers: How the BeVigilant\u2122 OraFusion\u2122 System is Redefining Early Oral Cancer Detection"}]},{"@type":"WebSite","@id":"https:\/\/vigilantbiosciences.com\/#website","url":"https:\/\/vigilantbiosciences.com\/","name":"Vigilant Biosciences\u00ae","description":"","publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vigilantbiosciences.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/vigilantbiosciences.com\/#organization","name":"Vigilant Biosciences\u00ae","url":"https:\/\/vigilantbiosciences.com\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/","url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","contentUrl":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","width":"1024","height":"1024","caption":"Vigilant Biosciences\u00ae"},"image":{"@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/VigilantBiosciences1","https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/"]},{"@type":"Person","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/4608808dbb426365f3f8178f8f584753","name":"Rachel LaBreck","image":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/755bafa85944af3f00f7cff2b0c64320800bf1afcaac410ee32f72b30f5bbe4a?s=96&d=mm&r=g","caption":"Rachel LaBreck"},"url":"https:\/\/vigilantbiosciences.com\/de\/author\/rachel-labreck\/"}]}},"_links":{"self":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts\/783","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/comments?post=783"}],"version-history":[{"count":0,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts\/783\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/media\/779"}],"wp:attachment":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/media?parent=783"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/categories?post=783"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/tags?post=783"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}